HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V K Vemuri Selected Research

AM 6527

9/2010Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V K Vemuri Research Topics

Disease

3Nausea
11/2010 - 11/2008
1Albuminuria
12/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2018
1Fibrosis (Cirrhosis)
12/2018
1Inflammation (Inflammations)
12/2018
1Obesity
10/2010
1Body Weight (Weight, Body)
10/2010
1Vomiting
09/2010
1Weight Gain
11/2008

Drug/Important Bio-Agent (IBA)

4CannabinoidsIBA
12/2018 - 11/2008
3AM6545IBA
12/2018 - 09/2010
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2018 - 11/2008
2RimonabantIBA
11/2010 - 11/2008
2AM 251 (AM251)IBA
09/2010 - 11/2008
1EndocannabinoidsIBA
12/2018
1nephrinIBA
12/2018
1NPHS2 proteinIBA
12/2018
1AlbuminsIBA
12/2018
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2018
1CreatinineIBA
12/2018
1Streptozocin (Streptozotocin)FDA Link
12/2018
1PerindoprilFDA LinkGeneric
12/2018
1N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA
11/2010
1Cannabinoid Receptor AntagonistsIBA
10/2010
1SolutionsIBA
09/2010
1Lithium ChlorideIBA
09/2010
1AM 6527IBA
09/2010
1AM4113IBA
11/2008

Therapy/Procedure

1Therapeutics
12/2018